Thermo Fisher Scientific announces a collaboration with Scinogy, specialists in closed, automated manufacturing systems for cell therapies, to develop and commercialize fit-for-purpose instrumentation and reagent systems aimed at improving productivity and scalability of cell and gene therapy manufacturing. The new Gibco CTS Rotea Counterflow Centrifugation System is a highly reproducible, closed cell processing system designed for separation, washing, and concentration of both autologous and small-scale allogeneic cell therapy samples. The system features: patented technology that can continuously process up to 20 liters of starting volume and deliver the concentrate in as little as 5 mL output containing up to 200 M cells/mL; intuitive, user-programmable software and an embedded camera to create and optimize a broad range of protocols; and a gentle fluidized bed to support high-throughput and low-shear processing with up to 97% cell recovery (cell type and process dependent).

Thermo Fisher Scientific